Hints and tips:
Related Special Reports
...The German champions beat Union Berlin 1-0 to close the gap on table toppers Bayer Leverkusen to four points. But none of that, frankly matters....
...The Dutch-Swiss ingredients and bioscience group just lowered its profit projection for the year....
...Claims escalation caught out Bayer and BP in their respective litigation battles. Worrisomely, the FDA says complaints have accelerated since May, with 168 deaths blamed on these devices....
...Dutch ingredients and bioscience group DSM and Swiss fragrance and flavour specialist Firmenich have announced a €41bn deal to create a “global powerhouse” in the specialist products needed for a booming...
...A record 271 cross-border licensing partnerships were agreed in 2020 between multinational groups including Roche, Bayer, AbbVie and Pfizer and Chinese pharma companies, according to data from consultancy...
...Cyber security and data governance Winner: Rajah & Tann Originality: 8; Leadership: 7; Impact: 9; Total: 24Rajah & Tann advised life sciences company Bayer on the use of drones to collect data on farms...
...Scott Bardo, an analyst at Berenberg, said the issue was “unlikely to descend into the next Bayer Monsanto”, referring to a settlement of up to $10.9bn over the potential carcinogenic effects of the German...
...“[Investors] have been fairly traumatised by the Bayer Monsanto situation and the Johnson & Johnson talc litigation,” said Bernstein analyst Lisa Clive, referring to two recent multibillion-dollar payouts...
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
...“Most of Europe has lost the benefits of GMOs,” agrees Liam Condon, head of crop science at Bayer....
...● Bayer jumped on hopes that a US court would slash the $289m of damages awarded by a jury over health effects of its Roundup weedkiller....
...The world’s biggest shipping container company AP Moller-Maersk is offloading its energy businesses to concentrate on transport and logistics, while German pharmaceuticals and chemicals group Bayer spun...
...Horizon Discovery half-year results One UK company that may see only upside from an international move is small gene editing bioscience group Horizon Discovery....
...“This is a revolutionary technology,” says Ofir Meir, chief technology officer of the Norwich-based Tropic Biosciences, owner of the Petri dishes....
...The WannaCry ransomware outbreak infected medical devices, disabling radiology equipment made by Bayer....
...But while ChemChina pledged to support Syngenta’s existing operations, in a recognition of the political sensitivities surrounding the deal, by contrast Dow and Bayer have sought to persuade investors of...
...On the basis of peers such as Clariant and Lanxess (itself a spin-off from Bayer in 2005), Akzo Nobel’s specialty chemicals division might attract an enterprise value of about €7.5bn....
...Panasonic Healthcare of Japan is working on similar services after its €1bn acquisition of a diabetes monitoring business from Bayer of Germany in June....
...Technologies Limited Dr Alexander Moscho Chief Executive, UK & Ireland, & Managing Director, Bayer Dr John B March Chief Executive, BigDNA Dr Erik Miljan Chief Executive, Biodivide Dr Simon Douglas...
...The cost to the planet of existing materials, such as plastics, simply isn’t counted, which makes sustainability quite a difficult path to take,” says Eben Bayer, a co-founder....
Record level of M&A activity is being driven by cheap capital and a race to develop new treatments
...Bayer of Germany in May paid $14bn for the over-the-counter business of Merck & Co of the US, while a month earlier Novartis agreed to form a consumer healthcare joint venture with GlaxoSmithKline....
...Qumu handled the task so smoothly that Bayer has since adopted it for all its videos....
...The first fruits of this strategy could be products produced by Ardea Biosciences, which Astra bought in 2012 for about $1.26bn (£777m)....
...Analysts at Barclays cut their rating on Bayer from “equal weight” to “underweight”, sending the German drugmaker’s shares falling 2.8 per cent to €73.57....
International Edition